Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

Background: The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir (DTG) plus lamivudine (3TC) have led to international guidelines recommending their use for treatment-naive HIV patients. In virologically suppressed patients, de-escalating from 3DRs to DTG plus either...

Descripción completa

Detalles Bibliográficos
Autores principales: Dueñas-Gutiérrez, Carlos, Buzón, Luis, Pedrero-Tomé, Roberto, Iribarren, José A., De los Santos, Ignacio, De la Fuente, Sara, Pousada, Guillermo, Moran, Miguel Angel, Moreno, Estela, Ferreira, Eva, Gómez, Julia, Troya, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145987/
https://www.ncbi.nlm.nih.gov/pubmed/37112915
http://dx.doi.org/10.3390/v15040936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145987/
https://www.ncbi.nlm.nih.gov/pubmed/37112915
http://dx.doi.org/10.3390/v15040936

Ejemplares similares